Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8

Journal of Investigative Dermatology

Volumn 132, Issue 11, 2012, Pages 2601-2609

  Toosi, Siavash ^a   Orlow, Seth J ^a   Manga, Prashiela ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MONOBENZONE; PHENOL DERIVATIVE; PROTEIN KINASE; PROTEIN KINASE RNA LIKE ENDOPLASMIC RETICULUM KINASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM; ENVIRONMENTAL STRESS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOCYTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; UNFOLDED PROTEIN RESPONSE; VITILIGO;

EID: 84867848664     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.181     Document Type: Article

References (52)

1. Alexandraki KI, Piperi C, Ziakas PD et al. (2008) Cytokine secretion in longstanding diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation. J Clin Immunol 28:314-21
2. Badri AM, Todd PM, Garioch JJ et al. (1993) An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 170:149-55 (Pubitemid 23192367)
3. Birol A, Kisa U, Kurtipek GS et al. (2006) Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo. Int J Dermatol 45:992-3 (Pubitemid 44145043)
4. Boissy RE, Liu YY, Medrano EE et al. (1991) Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in longterm cultures of melanocytes from vitiligo patients. J Invest Dermatol 97:395-404
5. Boissy RE, Manga P (2004) On the etiology of contact/occupational vitiligo. Pigment Cell Res 17:208-14 (Pubitemid 38724550)
6. Cullinan SB, Diehl JA (2004) PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 279:20108-17 (Pubitemid 38623455)
7. Cullinan SB, Diehl JA (2006) Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int J Biochem Cell Biol 38:317-32 (Pubitemid 41821881)
8. Elassiuty YE, Klarquist J, Speiser J et al. (2011) Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo. Exp Dermatol 20:496-501
9. Fonseca SG, Burcin M, Gromada J et al. (2009) Endoplasmic reticulum stress in beta-cells and development of diabetes. Curr Opin Pharmacol 9:763-70
10. Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8(Suppl 2):S3
11. Gargalovic PS, Gharavi NM, Clark MJ et al. (2006) The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 26:2490-6 (Pubitemid 44607470)
12. Guk KD, Kuprash DV (2011) [Interleukin-11, an IL-6 like cytokine]. Mol Biol (Mosk) 45:44-55
13. Hariharan V, Klarquist J, Reust MJ et al. (2010) Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. J Invest Dermatol 130:211-20
14. Im S, Hann SK, Kim HI et al. (1994) Biologic characteristics of cultured human vitiligo melanocytes. Int J Dermatol 33:556-62 (Pubitemid 24255802)
15. Ishihara K, Hirano T (2002) IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 13:357-68
16. James O, Mayes RW, Stevenson CJ (1977) Occupational vitiligo induced by p-tert-butylphenol, a systemic disease. Lancet 2:1217-9 (Pubitemid 8237205)
17. Jian Z, Li K, Liu L et al. (2011) Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway. J Invest Dermatol 131:1420-7
18. Kemp EH, Waterman EA, Weetman AP (2001) Autoimmune aspects of vitiligo. Autoimmunity 34:65-77 (Pubitemid 32888276)
19. Kirnbauer R, Charvat B, Schauer E et al. (1992) Modulation of intercellular adhesion molecule-1 expression on human melanocytes and melanoma cells: evidence for a regulatory role of IL-6, IL-7, TNF beta, and UVB light. J Invest Dermatol 98:320-6
20. Kogiso M, Tanouchi Y, Miki S et al. (1992) Characterization of T-cell subsets, soluble interleukin-2 receptors and interleukin-6 in Vogt-Koyanagi- Harada disease. Jpn J Ophthalmol 36:37-43
21. Krasagakis K, Garbe C, Zouboulis CC et al. (1995) Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res 139:169-82
22. Kroll TM, Bommiasamy H, Boissy RE et al. (2005) 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cellmediated killing: relevance to vitiligo. J Invest Dermatol 124: 798-806 (Pubitemid 40489508)
23. Le Poole C, Boissy RE (1997) Vitiligo. Semin Cutan Med Surg 16:3-14 (Pubitemid 27215608)
24. Le Poole IC, Boissy RE, Sarangarajan R et al. (2000) PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim 36:309-19 (Pubitemid 30619597)
25. Le Poole IC, van den Wijngaard RM, Westerhof W et al. (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148:1219-28 (Pubitemid 26108257)
26. Li YL, Yu CL, Yu HS (2000) IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes. J Invest Dermatol 115:969-73
27. Lipson KL, Fonseca SG, Urano F (2006) Endoplasmic reticulum stress-induced apoptosis and auto-immunity in diabetes. Curr Mol Med 6:71-7
28. Listopad J, Asadullah K, Sievers C et al. (2007) Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells. Exp Dermatol 16:661-70 (Pubitemid 47079596)
29. Manga P, Sheyn D, Yang F et al. (2006) A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo. Am J Pathol 169:1652-62 (Pubitemid 351181997)
30. Merksamer PI, Papa FR (2010) The UPR and cell fate at a glance. J Cell Sci 123:1003-6
31. Moretti S, Fabbri P, Baroni G et al. (2009) Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 24:849-57
32. Naughton GK, Eisinger M, Bystryn JC (1983) Antibodies to normal human melanocytes in vitiligo. J Exp Med 158:246-51 (Pubitemid 13073526)
33. Nguyen T, Nioi P, Pickett CB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284:13291-5
34. Nordlund JJ, Forget B, Kirkwood J et al. (1985) Dermatitis produced by applications of monobenzone in patients with active vitiligo. Arch Dermatol 121:1141-4 (Pubitemid 15018898)
35. Norose K, Yano A, Wang XC et al. (1994) Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 35:33-9 (Pubitemid 24046825)
36. Pfaffenbach KT, Nivala AM, Reese L et al. (2010) Rapamycin inhibits postprandial-mediated X-box-binding protein-1 splicing in rat liver. J Nutr 140:879-84
37. Ren Y, Yang S, Xu S et al. (2009) Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. PLoS Genet 5:e1000523
38. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-29 (Pubitemid 46985379)
39. Salvi M, Girasole G, Pedrazzoni M et al. (1996) Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 81:2976-9 (Pubitemid 26323895)
40. Shiota M, Eto M, Yokomizo A et al. (2010) Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition. Int J Oncol 36:1521-31
41. Spritz RA (2010) The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med 2:78
42. Todd DJ, Lee AH, Glimcher LH (2008) The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 8:663-74
43. Tsaytler P, Harding HP, Ron D et al. (2011) Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332:91-4
44. Tu CX, Gu JS, Lin XR (2003) Increased interleukin-6 and granulocytemacrophage colony stimulating factor levels in the sera of patients with non-segmental vitiligo. J Dermatol Sci 31:73-8
45. van den Boorn JG, Konijnenberg D, Dellemijn TA et al. (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129:2220-32
46. van den Boorn JG, Picavet DI, van Swieten PF et al. (2011) Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol 131:1240-51
47. Volkmann K, Lucas JL, Vuga D et al. (2011) Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease. J Biol Chem 286:12743-55
48. Westerhof W, d'Ischia M (2007) Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 20:345-59 (Pubitemid 47390114)
49. Wu WC, Hu DN, Gao HX et al. (2010) Subtoxic levels hydrogen peroxideinduced production of interleukin-6 by retinal pigment epithelial cells. Mol Vis 16:1864-73
50. Yildirim M, Baysal V, Inaloz HS et al. (2004) The role of oxidants and antioxidants in generalized vitiligo at tissue level. J Eur Acad Dermatol Venereol 18:683-6 (Pubitemid 39429707)
51. Yildirim M, Baysal V, Inaloz HS et al. (2003) The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 30:104-8 (Pubitemid 36368109)
52. Yu HS, Chang KL, Yu CL et al. (1997) Alterations in IL-6, IL-8, GM-CSF, TNFalpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo. J Invest Dermatol 108:527-9